Remove 2020 Remove Networking Remove Safety
article thumbnail

Are timely access and robust safety mutually exclusive?

pharmaphorum

And how can regulators balance timely access with robust safety? A European Federation of Pharmaceutical Industries and Associations (EFPIA) report published earlier this year, for example, compared the timelines of six regulatory agencies between 2011 and 2020. An abundance of caution? Accelerating safe access.

Safety 93
article thumbnail

The Rise of Audio Social Networks – Where Pharma Can Make an Impact

Pharma Marketing Network

Introducing new networks and features. In the summer of 2020, to stay-in-touch during the pandemic, a new audio-based, invite-only social media app, called Clubhouse , was launched that gathers people into audio chat rooms to discuss any topic imaginable. Today, the audio-only social network has over 6 million users.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 Insights From Re:Imagine Pharma Marketing 2020

Pharma Marketing Network

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact .

article thumbnail

Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor

Pharma Marketing Network

HBA Honorable Mentor 2020-21, Dr. Rod MacKenzie. Head of the Discovery Technology Center in Cambridge, Massachusetts, Head of Discovery Research in Ann Arbor, Michigan, and Head of Drug Safety R&D. The post Dr. Rod MacKenzie, 2020-2021 HBA Honorable Mentor appeared first on Pharma Marketing Network.

article thumbnail

Navigating the Regulatory Environment of Pharmaceutical Marketing: Balancing Patient Safety and Industry Innovation

Pharma Marketing Network

In this article, we will explore the regulatory environment of pharmaceutical marketing and how companies are navigating it to balance patient safety and industry innovation. In conclusion, navigating the regulatory environment of pharmaceutical marketing requires a delicate balance between patient safety and industry innovation.

Safety 52
article thumbnail

Updates on Salesforce Safety and Wellbeing Actions

Salesforce

million over the last two weeks, exceeding the totals in all of 2020. Amy Weaver President & Chief Legal Officer Salesforce * May 29, 2020 Another month in quarantine comes to a close and cities are slowly starting to reopen. The situation on the ground is dire. This is a time for compassion, imagination, and innovation.

Safety 52
article thumbnail

Eli Lilly reveals plans for new high-tech parenteral manufacturing site

European Pharmaceutical Review

Supporting European parenteral manufacture and supply Alongside expanding the company’s global parenteral product and device manufacturing network, the new facility will support the higher demand for Eli Lilly’s medicines, including its diabetes and obesity portfolio. This includes automation and high-speed manufacturing lines.